Hawaiʻi Lab Reporting Portal for COVID-19, Influenza (A/B), Respiratory Syncytial Virus (RSV) – (Click Here)
A laboratory director shall be responsible for ensuring testing facilities they preside over acknowledge and inform HDOH of the tested reportable diseases listed to the department in the manner as prescribed by the department, primarily through Electronic Laboratory Reporting (ELR). This may include, but is not limited to, other forms of secure data transfer using the internet as approved by the department, provided that diseases listed in Urgent and Immediate, as applicable, shall be reported by telephone.
“Electronic Laboratory Reporting (ELR)” means the automated transmission of laboratory data from a laboratory to the department in a structured, computer-readable format that complies with the department’s.
Technical standards and specifications, found here: ELR Technical Standards
For assistance with sign-up to the CDC provided portal (Simple Report) or reporting questions please contact us at: [email protected]
(Hawaii Administrative Rules Chapter 11-156)
Reporting Categories
- Urgent: Agents labeled “Urgent” shall be reported by telephone when a laboratory request is received.
- Immediate: Positive test results for agents labeled “Immediate” shall be reported by telephone within 24 hours of confirmation, followed by a written notification by mail or fax.
- Routine: Positive test results for agents and tests labeled “Routine” shall be reported within 3 days of confirmation.
- Confidential: Positive test results for agents and tests labeled “Confidential” shall be reported to the appropriate programs within three (3) working days of confirmation. However, HIV/AIDS and CD4 test results shall be reported by mail, telephone or electronic encryption.
- Upon request: Test results for agents shall be reported to the Disease Investigation Branch upon request
Communicable Disease Report Form (PDF)
| DISEASE | REPORTING CATEGORY | REPORT TO* |
|---|---|---|
| Group A Arboviruses (Venezuelan equine, Eastern equine, Western equine, California serogroup) | Urgent | Disease Investigation Branch |
| Group B Arboviruses (St. Louis, Powassan, West Nile, Japanese encephalitis virus) | Urgent | Disease Investigation Branch |
| Arenaviruses (Lassa, Marburg) | Urgent | Disease Investigation Branch |
| Bacillus anthracis | Urgent | Disease Investigation Branch |
| Bordetella pertussis | Immediate | Disease Investigation Branch |
| Burkholderia mallei | Urgent | Disease Investigation Branch |
| Burkholderia pseudomallei | Urgent | Disease Investigation Branch |
| Brucella spp. | Urgent | Disease Investigation Branch |
| Brugia malayi | Routine | Disease Investigation Branch |
| Brugia timori | Routine | Disease Investigation Branch |
| Campylobacter spp. | Routine | Disease Investigation Branch |
| CD4 T-lymphocyte count and percent | Confidential | HIV/AIDS Surveillance Program |
| Chlamydia psittaci | Immediate | Disease Investigation Branch |
| Chlamydia trachomatis, genital | Confidential | STD Prevention Program |
| Clostridium botulinum (Foodborne, wound, and infant) | Urgent | Disease Investigation Branch |
| Clostridium tetani | Routine | Disease Investigation Branch |
| Corynebacterium diphtheriae | Immediate | Disease Investigation Branch |
| Cryptosporidium spp. | Routine | Disease Investigation Branch |
| Cyclosporiasis | Routine | Disease Investigation Branch |
| Coxiella burnetii | Immediate | Disease Investigation Branch |
| Dengue virus | Immediate | Disease Investigation Branch |
| Entamoeba histolytica | Routine | Disease Investigation Branch |
| Enterococcus, Vancomycin-resistant | Routine | Disease Investigation Branch |
| Eosinophilic meningitis | Upon request | Disease Investigation Branch |
| Escherichia coli - shigatoxin producing, including type O157 | Routine | Disease Investigation Branch |
| Filoviruses (Ebola, Marburg) | Urgent | Disease Investigation Branch |
| Francisella tularensis | Urgent | Disease Investigation Branch |
| Giardia lamblia | Routine | Disease Investigation Branch |
| Haemophilus influenzae (from spinal fluid, blood, lung, or other normally sterile site) Report serotype and antimicrobial resistance if available. | Immediate | Disease Investigation Branch |
| Hantavirus | Immediate | Disease Investigation Branch |
| Hepatitis A virus (IgM positive); Also report liver function tests (AST {SGOT}, ALT {SGPT}) conducted at the same time | Immediate | Disease Investigation Branch |
| Hepatitis B virus; (surface antigen positive and/or anti-core IgM antibody positive) Also report liver function tests (AST {SGOT}, ALT {SGPT}) conducted at the same time for all patients who are HBsAg positive. | Routine | Disease Investigation Branch |
| Hepatitis C virus; Also report liver function tests (AST {SGOT}, ALT {SGPT}) conducted at the same time for all patients who are anti-HCV positive. | Routine | Disease Investigation Branch |
| Hepatitis E virus; Also report liver function tests (AST {SGOT}, ALT {SGPT}) conducted at the same time for all patients who are anti-HCE positive. | Routine | Disease Investigation Branch |
| HIV (Human Immunodeficiency Virus) and all HIV viral load tests | Confidential | HIV/AIDS Surveillance Program |
| Influenza virus (Report positive, negative and indeterminate results, and other viral isolates obtained through respiratory culture) | Routine | Disease Investigation Branch |
| Legionella pneumophila | Immediate | Disease Investigation Branch |
| Leptospira interrogans | Routine | Disease Investigation Branch |
| Listeria monocytogenes | Routine | Disease Investigation Branch |
| Liver function tests (AST {SGOT}, ALT {SGPT}) conducted at the same time on a patient who is HbsAg positive or anti-HCV positive. | Routine | Disease Investigation Branch |
| Lyssavirus spp. (Rabies) | Urgent | Disease Investigation Branch |
| Measles/Rubeola (IgM) | Immediate | Disease Investigation Branch |
| Mumps (IgM) | Routine | Disease Investigation Branch |
| Mycobacterium tuberculosis | Immediate | Tuberculosis Control Program |
| Mycobacterium leprae (AFB) positive biopsies and smears | Routine | Hansen's Disease Community Program |
| Neisseria gonorrhoeae (including identification of resistant strains) | Confidential | STD Prevention Program |
| Norovirus (NoV) PCR positive | Routine | Disease Investigation Branch |
| Plasmodium spp. | Routine | Disease Investigation Branch |
| Poliovirus | Immediate | Disease Investigation Branch |
| Respiratory Syncytial Virus (RSV) {Report positive and negative results, and other viral isolates obtained through respiratory culture} | Routine | Disease Investigation Branch |
| Rickettsia typhi | Routine | Disease Investigation Branch |
| Rubella (IgM) | Immediate | Disease Investigation Branch |
| Salmonella spp. (including typhi) | Routine | Disease Investigation Branch |
| SARS-Associated Coronavirus (SARS-CoV) | Urgent | Disease Investigation Branch |
| Shigella spp. | Routine | Disease Investigation Branch |
| Staphylococcus aureus, Methicillin-Resistant (MRSA) | Routine | Disease Investigation Branch |
| Staphylococcus aureus, Vancomycin-intermediate, (VISA) | Routine | Disease Investigation Branch |
| Vancomycin-resistant, Staphylococcus aureus (VRSA) | Urgent | Disease Investigation Branch |
| Streptococcus pyogenes, Group A (beta hemolytic, invasive disease including Streptococcal Toxic Shock Syndrome or other normally sterile site, but not including pharyngitis) | Routine | Disease Investigation Branch |
| Streptococcus pneumoniae isolated from a normally sterile site, report antimicrobial susceptibility. | Routine | Disease Investigation Branch |
| Toxoplasma gondii | Routine | Disease Investigation Branch |
| Treponema pallidum | Confidential | STD Prevention Program |
| Trichinella spiralis | Routine | Disease Investigation Branch |
| West Nile Virus IgM | Urgent | Disease Investigation Branch |
| Wuchereria bancrofti | Routine | Disease Investigation Branch |
| Varicella (IgM) | Routine | Disease Investigation Branch |
| Variola virus | Urgent | Disease Investigation Branch |
| Vibrio cholerae | Urgent | Disease Investigation Branch |
| Vibrio spp. (other than cholerae) | Routine | Disease Investigation Branch |
| Yellow fever virus | Urgent | Disease Investigation Branch |
| Yersinia pestis | Urgent | Disease Investigation Branch |
| Yersinia spp. (other than pestis) | Routine | Disease Investigation Branch |
*REPORT TO:
Disease Investigation Branch
O’ahu
Phone: (808) 586-4586
Fax: (808) 586-4595
Hawai’i
Phone: (808) 933-0912
Fax: (808) 933-0400
Kaua’i
Phone: (808) 241-3563
Fax: (808) 241-3480
Maui
Phone: (808) 984-8213
Fax: (808) 243-5141
After hours, weekends, and holidays report to: 1-800-360-2575
Tuberculosis Control Program
1700 Lanakila Avenue, Ground Floor, Honolulu, HI 96817, Attn: Registry – Confidential
Phone: (808) 832-3534
Fax: (808) 832-5624
STD Prevention Program
3627 Kilauea Avenue, Room 304, Honolulu, HI 96816
Phone: (808) 733-9281
Fax: (808) 733-9291
HIV/AIDS Surveillance Program (Confidential)
3627 Kilauea Avenue, Room 306, Honolulu, HI 96816
Phone: (808) 733-4079
Hansen’s Disease Community Program
3627 Kilauea Avenue Room 102, Honolulu, HI 96816
Phone: (808) 733-9831
Fax: (808) 733-9836